Norges Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-565,956
| Closed | -$52.6M | – | 2267 |
|
|
2021
Q4 | $52.6M | Buy |
565,956
+20,599
| +4% | +$1.36M | 0.01% | 912 |
|
|
2021
Q3 | $32.5M | Sell |
545,357
-37,608
| -6% | -$2.22M | 0.01% | 1160 |
|
|
2021
Q2 | $39.8M | Sell |
582,965
-13,562
| -2% | -$884K | 0.01% | 1106 |
|
|
2021
Q1 | $41.4M | Sell |
596,527
-177,182
| -23% | -$13.6M | 0.01% | 1086 |
|
|
2020
Q4 | $59.4M | Sell |
773,709
-6,598
| -0.8% | -$495K | 0.01% | 859 |
|
|
2020
Q3 | $58.4M | Sell |
780,307
-79,192
| -9% | -$5.28M | 0.02% | 759 |
|
|
2020
Q2 | $54.1M | Buy |
859,499
+29,727
| +4% | +$1.64M | 0.02% | 785 |
|
|
2020
Q1 | $34.9M | Sell |
829,772
-169,635
| -17% | -$7.78M | 0.01% | 884 |
|
|
2019
Q4 | $45.4M | Hold |
999,407
| – | – | 0.01% | 982 |
|
|
2019
Q3 | $45.7M | Buy |
999,407
+115,444
| +13% | +$6.49M | 0.01% | 919 |
|
|
2019
Q2 | $51.8M | Buy |
883,963
+204,413
| +30% | +$10.6M | 0.02% | 848 |
|
|
2019
Q1 | $30.5M | Buy |
679,550
+130,806
| +24% | +$6M | 0.01% | 1199 |
|
|
2018
Q4 | $21.4M | Buy |
548,744
+383,323
| +232% | +$15.1M | 0.01% | 1350 |
|
|
2018
Q3 | $7.61M | Buy |
+165,421
| New | +$6.71M | ﹤0.01% | 1892 |
|
|
2018
Q2 | – | Sell |
-67,591
| Closed | -$2.67M | – | 2184 |
|
|
2018
Q1 | $2.67M | Hold |
67,591
| – | – | ﹤0.01% | 1974 |
|
|
2017
Q4 | $2.3M | Hold |
67,591
| – | – | ﹤0.01% | 1961 |
|
|
2017
Q3 | $1.72M | Hold |
67,591
| – | – | ﹤0.01% | 1989 |
|
|
2017
Q2 | $1.14M | Sell |
67,591
-36,062
| -35% | -$494K | ﹤0.01% | 2036 |
|
|
2017
Q1 | $1.51M | Sell |
103,653
-22,080
| -18% | -$327K | ﹤0.01% | 2020 |
|
|
2016
Q4 | $1.78M | Hold |
125,733
| – | – | ﹤0.01% | 1978 |
|
|
2016
Q3 | $2.1M | Hold |
125,733
| – | – | ﹤0.01% | 1977 |
|
|
2016
Q2 | $2.15M | Sell |
125,733
-7,182
| -5% | -$128K | ﹤0.01% | 1997 |
|
|
2016
Q1 | $2.62M | Hold |
132,915
| – | – | ﹤0.01% | 1966 |
|
|
2015
Q4 | $2.52M | Hold |
132,915
| – | – | ﹤0.01% | 2000 |
|
|
2015
Q3 | $2.54M | Sell |
132,915
-22,371
| -14% | -$760K | ﹤0.01% | 2003 |
|
|
2015
Q2 | $7.21M | Sell |
155,286
-25,972
| -14% | -$1.13M | ﹤0.01% | 1779 |
|
|
2015
Q1 | $7.92M | Sell |
181,258
-11,820
| -6% | -$549K | ﹤0.01% | 1748 |
|
|
2014
Q4 | $6.7M | Hold |
193,078
| – | – | ﹤0.01% | 1821 |
|
|
2014
Q3 | $8.09M | Sell |
193,078
-193,078
| -50% | -$8.62M | ﹤0.01% | 1697 |
|
|
2014
Q2 | $22.6M | Buy |
386,156
+218,343
| +130% | +$13.7M | 0.01% | 1564 |
|
|
2014
Q1 | $10.6M | Hold |
167,813
| – | – | 0.01% | 1551 |
|
|
2013
Q4 | $9.82M | Hold |
167,813
| – | – | 0.01% | 1585 |
|
|
2013
Q3 | $8.84M | Buy |
167,813
+55,711
| +50% | +$3.74M | 0.01% | 1632 |
|
|
2013
Q2 | $8.63M | Buy |
+112,102
| New | +$9.15M | 0.01% | 1565 |
|
Norges Bank's ARNA Position: Q1 2022 in Review
Norges Bank sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 565,956 shares — an estimated $52.6M sold.
Norges Bank first reported a position in ARNA in Q2 2013 and held it in 34 quarters. The position peaked at $59.4M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Norges Bank reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Norges Bank sold 565,956 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $52.6M.
- Norges Bank first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 34 quarters.
- Norges Bank's Arena Pharmaceuticals Inc position peaked at $59.4M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Norges Bank's 13F filing for Q1 2022, filed 9 May 2022.